Is Synchronization More Effective During Noninvasive Ventilation in Immediately Extubated Preterm Infants?
N_SIMV
1 other identifier
interventional
18
1 country
1
Brief Summary
The purpose of this study is the examination of the hypothesis that synchronized nasal IMV as compared to non-synchronized nasal IMV will decrease breathing effort in preterm infants immediately after extubation when recovering from Respiratory distress syndrome (RDS). Another objective is to examine the effects for synchronized non-invasive mechanical ventilation on gas exchange and cerebral oxygen saturation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2012
CompletedFirst Submitted
Initial submission to the registry
August 2, 2012
CompletedFirst Posted
Study publicly available on registry
August 14, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2013
CompletedJune 27, 2013
June 1, 2013
1.2 years
August 2, 2012
June 26, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
phasic esophageal pressure deflection
4 hours
Secondary Outcomes (2)
Cerebral oxygen saturation
4 hours
Arterial oxygen saturation
4 hours
Study Arms (2)
S-nIMV
EXPERIMENTALnIMV synchronized using abdominal pressure capsule sensor device
nIMV
PLACEBO COMPARATORnon-synchronized nasal intermittent mandatory ventilation group
Interventions
Eligibility Criteria
You may qualify if:
- Preterm infants recovering from respiratory failure with the following criteria were eligible for this study.
- Gestational age \<32 wks, those who are on invasive mechanical ventilation, recovering from RDS, and ready for extubation as judged by the clinical team.
- Informed consent available.
You may not qualify if:
- Infants with major congenital anomalies involving the CNS, lung (i.e. lung hypoplasia, active air leaks) or the heart (ASD, VSD allowed), or known neuromuscular disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Hospital University of Ulm
Ulm, Baden-Wüttemberg, 89075, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hummler Helmut, Prof. Dr
University of Ulm
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof. Dr. Helmut Hummler
Study Record Dates
First Submitted
August 2, 2012
First Posted
August 14, 2012
Study Start
July 1, 2012
Primary Completion
September 1, 2013
Last Updated
June 27, 2013
Record last verified: 2013-06